InMode (INMD) Competitors $14.81 +0.60 (+4.22%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$14.69 -0.12 (-0.81%) As of 08/22/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INMD vs. NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, AORT, EYE, and ENOVShould you be buying InMode stock or one of its competitors? The main competitors of InMode include Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), National Vision (EYE), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. InMode vs. Its Competitors Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion National Vision Enovis InMode (NASDAQ:INMD) and Envista (NYSE:NVST) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends. Do institutionals and insiders have more ownership in INMD or NVST? 68.0% of InMode shares are owned by institutional investors. 6.9% of InMode shares are owned by company insiders. Comparatively, 0.7% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is INMD or NVST more profitable? InMode has a net margin of 44.50% compared to Envista's net margin of 2.11%. InMode's return on equity of 18.38% beat Envista's return on equity.Company Net Margins Return on Equity Return on Assets InMode44.50% 18.38% 16.35% Envista 2.11%4.84%2.68% Do analysts rate INMD or NVST? InMode presently has a consensus price target of $18.04, suggesting a potential upside of 21.82%. Envista has a consensus price target of $20.92, suggesting a potential downside of 3.44%. Given InMode's higher probable upside, equities analysts plainly believe InMode is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InMode 0 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.13Envista 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33 Which has more volatility & risk, INMD or NVST? InMode has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Envista has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500. Does the media favor INMD or NVST? In the previous week, Envista had 3 more articles in the media than InMode. MarketBeat recorded 7 mentions for Envista and 4 mentions for InMode. InMode's average media sentiment score of 1.61 beat Envista's score of 1.32 indicating that InMode is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Envista 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, INMD or NVST? InMode has higher earnings, but lower revenue than Envista. InMode is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInMode$394.82M2.37$181.27M$2.476.00Envista$2.55B1.41-$1.12B$0.3267.72 SummaryInMode beats Envista on 11 of the 17 factors compared between the two stocks. Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$898.20M$10.84B$5.76B$9.58BDividend YieldN/A1.87%4.41%4.10%P/E Ratio6.0020.9031.1026.05Price / Sales2.3729.67432.51103.82Price / Cash7.7924.5537.7358.48Price / Book1.493.519.536.61Net Income$181.27M$211.77M$3.26B$265.56M7 Day Performance3.21%4.44%2.10%1.97%1 Month Performance-0.80%8.85%2.81%-0.36%1 Year Performance-8.86%-9.03%30.56%19.03% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode1.9906 of 5 stars$14.81+4.2%$18.04+21.8%-4.4%$898.20M$394.82M6.00480Positive NewsNVSTEnvista3.8499 of 5 stars$20.75+0.5%$20.92+0.9%+20.6%$3.45B$2.51B64.8312,300LIVNLivaNova1.736 of 5 stars$53.27-0.8%$59.29+11.3%+21.4%$2.91B$1.25B-13.692,900Positive NewsAnalyst ForecastWRBYWarby Parker2.1262 of 5 stars$27.38+0.9%$24.06-12.1%+94.9%$2.88B$771.32M-391.093,780Analyst UpgradeINSPInspire Medical Systems4.9366 of 5 stars$88.28+0.6%$165.62+87.6%-48.6%$2.61B$802.80M51.031,246Positive NewsShort Interest ↓LQDALiquidia Technologies3.5732 of 5 stars$27.72+6.8%$31.40+13.3%+178.7%$2.39B$14M-16.3150PRCTPROCEPT BioRobotics3.57 of 5 stars$40.71-2.1%$74.88+83.9%-48.6%$2.27B$224.50M-26.26430LMATLeMaitre Vascular2.2402 of 5 stars$95.04-0.9%$98.00+3.1%+16.4%$2.15B$219.86M46.14490Positive NewsAORTArtivion3.5705 of 5 stars$42.810.0%$39.80-7.0%+75.6%$2.02B$388.54M-101.921,600Analyst ForecastInsider TradeEYENational Vision2.8254 of 5 stars$23.87+5.0%$24.73+3.6%+142.5%$1.89B$1.82B-132.6113,411Positive NewsENOVEnovis4.4882 of 5 stars$29.51-0.1%$51.00+72.8%-28.7%$1.69B$2.11B-2.077,367 Related Companies and Tools Related Companies NVST Alternatives LIVN Alternatives WRBY Alternatives INSP Alternatives LQDA Alternatives PRCT Alternatives LMAT Alternatives AORT Alternatives EYE Alternatives ENOV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INMD) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.